Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add filters








Language
Year range
1.
Article in Chinese | WPRIM | ID: wpr-997662

ABSTRACT

ObjectiveTo explore the clinical efficacy and safety of Qifu Yixin prescription in treating chronic heart failure in the patients with the syndrome of heart Qi deficiency, so as to provide clinical evidence for the treatment of chronic heart failure with this prescription and promote the clinical application and transformation of this prescription. MethodA total of 106 chronic heart failure patients with the syndrome of heart Qi deficiency who met the criteria in Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine (TCM) from September 2022 to May 2023 were selected and randomized into an observation group (53 cases) and a control group (53 cases). Both groups received routine Western medicine treatment. In addition, the observation group received Qifu Yixin prescription, while the control group received placebo. The treatment course for both groups was 12 weeks. The New York heart association (NYHA) cardiac function grading, N-terminal pro-B-type natriuretic peptide (NT-proBNP), soluble growth-stimulating expression gene 2 (sST2), left ventricular ejection fraction (LVEF), the ratio of early diastolic maximum mitral flow velocity (E) to early diastolic mitral annular motion velocity (e') (E/e'), left ventricular end diastolic diameter (LVEDD), TCM syndrome scores, 6-minute walking test (6MWT), Minnesota Living with Heart Failure Questionnaire (MLHFQ), and Kansas City Cardiomyopathy Questionnaire (KCCQ) were determined before and after treatment. ResultFinally, 102 patients were included for analysis, including 51 patients in the observation group and 51 patients in the control group. After treatment, 42 patients in the observation group showed improved cardiac function grading, with a total response rate of 82.35%, and 32 patients in the control group showed improved cardiac function grading, with a total response rate of 62.75%. The total response rate regarding the cardiac function in the observation group was higher than that in the control group (χ2=4.923, P<0.05). The observation group outperformed the control group in lowering the NT-proBNP level, elevating LVEF, decreasing the E/e' ratio (P<0.05), reducing LVEDD and sST2 levels, and recovering TCM syndrome score, 6MWT score, MLHFQ score, and KCCQ score (P<0.05). None of the safety indexes in the two groups showed abnormal values before and after treatment, and no serious adverse reaction was observed. ConclusionQifu Yixin prescription can improve the heart function, exercise tolerance, and quality of life and alleviate the TCM syndrome of the chronic heart failure patients with the syndrome of heart Qi deficiency by inhibiting myocardial fibrosis.

2.
China Pharmacy ; (12): 2204-2208, 2022.
Article in Chinese | WPRIM | ID: wpr-943058

ABSTRACT

OBJECTIVE To study the pharmacokinetic characters of Baihe -zhimu decoction (BZD) and its single herbs . METHODS A liquid chromatography -tandem mass spectrometry method was developed to simultaneously determine the blood concentrations of 7 effective components (neomangiferin,mangiferin,regaloside A ,regaloside Ⅰ,timosaponin B Ⅱ,timosaponin E and timosaponin A Ⅲ)in rats after oral administration of BZD extract ,single herb extract of Lilium brownii and Anemarrhena asphodeloides. The pharmacokinetic parameters were calculated . RESULTS The linear range of 7 effective components as neomangiferin were 1-1 000,1-1 000,0.1-100,0.4-400,1-1 000,0.1-100 and 0.5-500 ng/mL(all r>0.998),respectively. The accuracy of the method ranged from 87.50% to 115.00%,and the RSDs of intra -day and inter -day precision were 0.62%-14.35%. RSDs of matrix factor were 2.68%-14.03%,and deviation of stability were within ±15%. Compared with L. brownii and A. asphodeloides,AUC0-24h,AUC0-∞ and cmax of 7 effective components in BZD were increased significantly (P<0.05),while CL z/Fof 6 effective components (except timosaponin B Ⅱ)decreased significantly (P<0.05). CONCLUSIONS BZD can increase the absorption of effective ingredients in rats ,slow down their elimination and prolong their retention time ,indicating pharmacokinetic behaviors of effective components in BZD possess more advantages over those of single herbs .

3.
China Pharmacy ; (12): 2520-2524, 2021.
Article in Chinese | WPRIM | ID: wpr-887434

ABSTRACT

OBJECTIVE:To explo re the clinical characteristics of voriconazole-induced neurological ADR and the occurrence of hypokalemia and hyponatremia before ADR. METHODS :The medical records of 411 patients receiving voriconazole therapy , who admitted to our hospital from January 2018 to November 2020,were retrospectively analyzed. The general information of all patients,including sex ,age,body weight ,type of infection ,underlying disease ,type of pathogenic fungal infection and administration route of voriconazole ,maintenance dose ,blood drug concentration ,were collected. The basic information of patients with neurological ADR ,including sex ,age,types of infection ,underlying disease ,drug combination ,occurrence time and clinical manifestations ,were collected . The levels of blood potassium ,blood sodium and liver function indexes (ALT,AST, γ-GT,ALP,total bilirubin ,direct bilirubin )within 3 days before the neurological ADR were also collected. The relationship of neurological ADR with voriconazole trough concentration ,blood potassium and blood sodium levels was analyzed. RESULTS : Among 411 patients,31(7.54%)patients suffered from neurological ADR ,which were higher in male (64.52%)than in female (35.48%),mainly in patients aged 50 and over (74.20%). The major infection type was lung infection (96.77%). Among 31 patients with neurological ADR ,26 patients suffered from neurological ADR after 1-7 days after voriconazole administration , accounting for 83.87%. Thirty patients received intravenous drip ,accounting for 96.77%. The incidence of neurological ADR in patients with voriconazole trough concentration >5.0 μ g/mL (8.99%)was significantly higher than that in patients with trough concentration ≤5.0 μg/mL(3.42%,χ2=4.91,P=0.027). The clinical manifestations of the patients were mainly 023-68766797。E-mail:cheng7zhu@163.com hallucinations(32.35%),irritability(32.35%)and poor sleep (17.65%),etc. Within 3 days before 30 patients,receiving related indexes test ,suffered from neurological ADR ,16 patients(53.33%)had hypokalemia and 12 patients(40.00%) had hyponatremia ,which w ere significantly higher than the incidence of hypokalemia (24.74%,P=0.001)and hyponatremia (12.89%,P<0.001)in those without neurological ADR . There were 8,10,7,13,7 and 10 patients with ALT ,AST,ALP, γ-GT,total bilirubin and direct bilirubin increased. In 31 patients with neurological ADR ,the neurological ADR were relieved or disappeared after reducing the dosage or discontinuing voriconazole. CONCLUSIONS :The neurological ADR of voriconazole mostly occurs 1-7 days after voriconazole administration ,mainly by intravenous drip ,mostly in male and people aged 50 and over. The occurrence of neurological ADR may be related to trough concentration of voriconazole ,and most patients suffer from hypokalemia or hyponatremia before the occurrence of ADR .

4.
China Pharmacy ; (12): 2946-2951, 2019.
Article in Chinese | WPRIM | ID: wpr-817474

ABSTRACT

OBJECTIVE: To establish the method for simultaneous determination of clopidogrel (CLP), its intermediate metabolite (2-O-CLP), inactive metabolite (CLPCA) and active metabolite (CLPTM) in human plasma. METHODS: Totally 90 patients diagnosed as stroke were selected from the First Affiliated Hospital of Army Medical University. They were given one CLP tablet (75 mg/tablet) orally on an empty stomach in the morning. Blood samples were collected 2 h after taking the tablet. CLPTM- D was formed by derivation of CLPTM with 2-bromo-3’-methoxyacetophenone and extracted by precipitation of acetonitrile protein together with the other three substances to be measured. LC-MS/MS method was adopted. The determination was performed on Agilent poroshell 120 EC-C18 column with mobile phase consisted of acetonitrile (0.1% formic acid) and water (0.1% formic acid) (90 ∶ 10, V/V). The quantitation analysis was performed using multiple reaction monitoring at the specific ion transitions of m/z 308.1→198.1 (CLPCA), 322.3→212.0 (CLP), 338.3→155.0 (2-O-CLP), 504.4→354.1 (CLPTM-D) and 264.0→154.1 (ticlopidine, internal standard), respectively. RESULTS: The retention time of CLPCA, CLP, 2-O-CLP, CLPTM-D and internal standard were 2.01, 3.32, 2.83, 2.68, 1.87 min, respectively. The linear range of CLPCA, CLP, 2-O-CLP and CLPTM-D were 100-10 000, 0.2-20, 0.3-30, 0.5-50 ng/mL (all r≥0.999 5). The intra-day and inter-day RSD were all less than 9.5% (n=5). Accuracy ranged from 93.5%-98.9% (n=5), and extraction recovery was from 85.4% to 95.9% (n=5). The matrix effect ranged from 2.7%-6.2% (n=5). In stability tests (storing at -80 ℃ for 3 months, 3 freeze-thaw cycles, storing at 4 ℃ for 8 h), RE of CLP, CLPCA and CLPTM-D were all lower than 10.0% (n=5). CONCLUSIONS: Established LC-MS/MS method has the advantages of high specificity, accuracy and reliability, and can be used to detect the concentration of CLP and its three metabolites in human plasma.

5.
Zhonghua xinxueguanbing zazhi ; (12): 611-616, 2018.
Article in Chinese | WPRIM | ID: wpr-807116

ABSTRACT

Object@#To explore the electrocardiographic characteristics of ventricular arrhythmias (VAs) originating from tricuspid annulus region.@*Methods@#Present study included 169 consecutive patients undergoing catheter ablation of VAs from tricuspid annulus origin in our department from August 2007 to September 2016. Based on the origin sites, the patients were divided into two subgroups, the free wall group (81 cases) and septal wall group (88 cases). Based on the location, patients in the free wall group were classified into anterolateral (22 cases), lateral (26 cases) and posterolateral (33 cases) subgroups. Patients in the septal group were classified into anteroseptal (10 cases), midseptal (71 cases) and posteroseptal (7 cases) subgroups. We analyzed the electrocardiographic features of these patients and in 87 patients with PVCs/VT originating from right ventricular outflow tract.@*Results@#(1) A positive R wave inⅠ, aVL, V5-V6 leads were found among most of patients, only few cases originating from tricuspid annulus anteroseptum group and tricuspid annulus anterolateral group demonstrated qr or qs pattern in aVL lead. 97.53% (79/81) patients demonstrated rS pattern in V1-V3 leads with VAs originating from tricuspid annulus free wall, and 9/10 patients demonstrated rS pattern in V1 lead with VAs originating from anteroseptum, and 97.44% (76/78) patients demonstrated QS pattern in V1 lead with VAs originating from midseptum and posteroseptum. Precordial lead transition zone was on or behind V3 for tricuspid annulus free wall group (96.3%, 78/81), but in front of V3 for tricuspid annulus septum wall group (47.73%, 42/88) (P<0.01). The S wave's amplitude smaller than-1.81 mV in lead V2 can be used as a cutoff value to identify if PVC/VT is originating from free wall or septum of TA. R wave in inferior wall leads was found among 98.85% (86/87) patients with PVCs/VT originating from right ventricular outflow tract.@*Conclusion@#A positive R wave in Ⅰ, aVL, V5-V6 leads was found among most of patients with idiopathic ventricular arrhythmias originating from the tricuspid annulus regions, but VAs originating from different portions of tricuspid annulus area have distinct electrocardiographic characteristics.

6.
Article in Chinese | WPRIM | ID: wpr-502772

ABSTRACT

Neomangiferin, a natural C-glucosyl xanthone, has recently received a great deal of attention due to its multiple biological activities. In this study, a rapid and sensitive ultra-high performance liquid chroma-tography tandem mass spectrometry (UHPLC–MS/MS) method for the quantification of neomangiferin in rat plasma was developed. Using chloramphenicol as an internal standard (IS), plasma samples were subjected to a direct protein precipitation process using methanol (containing 0.05% formic acid). Quan-tification was performed by multiple reactions monitoring (MRM) method, with the transitions of the parent ions to the product ions of m/z 583.1-330.9 for NG and m/z 321.1-151.9 for IS. The assay was shown to be linear over the range of 0.2–400 ng/mL, with a lower limit of quantification of 0.2 ng/mL. Mean recovery of neomangiferin in plasma was in the range of 97.76%–101.94%. Relative standard deviations (RSDs) of intra-day and inter-day precision were both o 10%. The accuracy of the method ranged from 94.20%to 108.72%. This method was successfully applied to pharmacokinetic study of neomangiferin after intravenous (2 mg/kg) and intragastric (10 mg/kg) administration for the first time. The oral absolute bioavailability of neomangiferin was estimated to be 0.53%7 0.08%with an elimination half-life (t1/2) value of 2.74 7 0.92 h, indicating its poor absorption and/or strong metabolism in vivo.

SELECTION OF CITATIONS
SEARCH DETAIL